Portfolio Holdings Detail for ISIN IE00B441G979
| Stock Name / Fund | iShares MSCI World EUR Hedged UCITS ETF (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares V Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300QETNU1W5JY7Z94 |
| ETF Ticker | IBCH(EUR) F |
| ETF Ticker | IBCH.DE(EUR) CXE |
| ETF Ticker | IWDE.AS(EUR) CXE |
| ETF Ticker | IWDE.LS(EUR) CXE |
| ETF Ticker | IWDE.MI(EUR) CXE |
| ETF Ticker | IWDEz(EUR) CXE |
| ETF Ticker | IWDE(EUR) Euronext Amsterdam |
Holdings detail for BMRN
| Stock Name | Biomarin Pharmaceutical Inc |
| Ticker | BMRN(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US09061G1013 |
| LEI | NSLL8ITTRR0J5HEMR848 |
Show aggregate BMRN holdings
News associated with BMRN
- BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $104.00 at The Goldman Sachs Group
- BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price target cut by The Goldman Sachs Group from $124.00 to $104.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Oppenheimer raised BioMarin Pharmaceutical […] - 2025-05-06 05:56:44
- NewEdge Advisors LLC Purchases 3,121 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- NewEdge Advisors LLC increased its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 1,200.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,381 shares of the biotechnology company’s stock after buying an additional 3,121 shares during the […] - 2025-05-02 08:18:50
- BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.com
- StockNews.com upgraded shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) from a buy rating to a strong-buy rating in a research report sent to investors on Friday. BMRN has been the topic of several other reports. Scotiabank lifted their price objective on shares of BioMarin Pharmaceutical from $78.00 to $80.00 and gave the stock a […] - 2025-04-28 05:56:51
- After Hours Most Active for Apr 22, 2025 : TSLL, TSLA, NVDA, VZ, BMRN, CNH, KVUE, CM, CSCO, CLF, BAC, AAPL
- The NASDAQ 100 After Hours Indicator is down -.37 to 18,276.04. The total After hours volume is currently 133,305,492 shares traded.The following are the most active stocks for the after hours session: Direxion Daily TSLA Bull 2X Shares (TSLL) is -0.1 at $7.29, with 10,940,890 s - 2025-04-22 20:24:52
- Analysts Expect 26% Upside For The Holdings of IWS
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-17 12:43:07
- Federated Hermes Inc. Sells 854 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Federated Hermes Inc. lessened its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,999 shares of the biotechnology company’s stock after selling 854 shares during the period. Federated Hermes Inc.’s holdings in BioMarin Pharmaceutical were worth $1,249,000 at the end of […] - 2025-04-15 08:34:53
- CIBC Private Wealth Group LLC Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- CIBC Private Wealth Group LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 64.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 596 shares of the biotechnology company’s stock after acquiring an additional 233 shares during […] - 2025-04-10 08:53:11
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $94.00 Consensus Target Price from Brokerages
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seventeen have issued a buy rating on the company. The average 12-month target price […] - 2025-04-02 05:35:01
- Korea Investment CORP Purchases 131,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Korea Investment CORP grew its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 362.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,903 shares of the biotechnology company’s stock after purchasing an additional 131,600 shares during the quarter. Korea […] - 2025-03-31 08:45:10
- Traders Purchase High Volume of Call Options on BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of some unusual options trading on Thursday. Traders bought 5,111 call options on the company. This represents an increase of 273% compared to the typical volume of 1,372 call options. Analyst Ratings Changes BMRN has been the subject of several recent analyst reports. Wedbush […] - 2025-03-28 07:07:10
- 5 Historically Cheap Growth Stocks to Buy With Confidence in the Wake of the Nasdaq Correction
- Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. - 2025-03-27 09:06:00
- Natixis Advisors LLC Purchases Shares of 19,738 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Natixis Advisors LLC acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 19,738 shares of the biotechnology company’s stock, valued at approximately $1,297,000. A number of other institutional investors and hedge […] - 2025-03-26 07:50:56
- EverSource Wealth Advisors LLC Sells 6,469 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- EverSource Wealth Advisors LLC lowered its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 91.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 634 shares of the biotechnology company’s stock after selling 6,469 shares during the quarter. EverSource Wealth Advisors […] - 2025-03-21 08:25:03
- BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Rating Upgraded by StockNews.com
- BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Tuesday. BMRN has been the subject of several other research reports. Oppenheimer upgraded shares of BioMarin Pharmaceutical from a “market perform” rating to an “outperform” rating […] - 2025-03-18 06:12:54
- How The Pieces Add Up: FBT Targets $219
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-17 11:50:34
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Acquired by M&T Bank Corp
- M&T Bank Corp lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.5% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,085 shares of the biotechnology company’s stock after purchasing an additional 616 shares during the period. M&T Bank Corp’s holdings in BioMarin Pharmaceutical were worth $466,000 at the […] - 2025-03-14 08:08:58
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Consensus Rating of “Moderate Buy” by Brokerages
- Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-four brokerages that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seventeen have issued a buy recommendation on the company. The average 12-month price […] - 2025-03-05 07:12:53
- Y Intercept Hong Kong Ltd Has $310,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Y Intercept Hong Kong Ltd lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 83.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,711 shares of the biotechnology company’s stock after selling 23,519 shares during the quarter. […] - 2025-03-04 09:05:03
- Sanctuary Advisors LLC Trims Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Sanctuary Advisors LLC lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 76.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,045 shares of the biotechnology company’s stock after selling 16,288 shares during the quarter. Sanctuary […] - 2025-03-04 08:22:48
- New York State Common Retirement Fund Sells 4,600 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- New York State Common Retirement Fund reduced its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 93,645 shares of the biotechnology company’s stock after selling 4,600 shares during […] - 2025-02-28 09:04:56
- Principal Securities Inc. Acquires 339 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Principal Securities Inc. boosted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,749 shares of the biotechnology company’s stock after buying an additional 339 shares […] - 2025-02-26 10:10:52
- Asset Management One Co. Ltd. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Asset Management One Co. Ltd. raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 76,785 shares of the biotechnology company’s stock after acquiring an additional 283 shares during the period. Asset Management One Co. Ltd.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-02-19 10:44:54
- Rhumbline Advisers Has $36.56 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Rhumbline Advisers boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 2.0% in the fourth quarter, Holdings Channel reports. The firm owned 556,255 shares of the biotechnology company’s stock after purchasing an additional 11,025 shares during the quarter. Rhumbline Advisers’ holdings in BioMarin Pharmaceutical were worth $36,563,000 as of its most recent […] - 2025-02-19 09:03:32
- Entropy Technologies LP Invests $500,000 in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Entropy Technologies LP acquired a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,604 shares of the biotechnology company’s stock, valued at approximately $500,000. Other large […] - 2025-02-13 10:12:51
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Stock Holdings Trimmed by State of Alaska Department of Revenue
- State of Alaska Department of Revenue cut its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 25.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 21,730 shares of the biotechnology company’s stock after selling 7,495 shares during the quarter. State […] - 2025-02-13 09:38:52
- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Decreased by Janney Montgomery Scott LLC
- Janney Montgomery Scott LLC trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 34.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,671 shares of the biotechnology company’s stock after selling 4,029 shares during the quarter. Janney Montgomery Scott LLC’s […] - 2025-02-10 18:10:54
- Robeco Institutional Asset Management B.V. Trims Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
- Robeco Institutional Asset Management B.V. cut its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 58.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 86,574 shares of the biotechnology company’s stock after selling 124,092 shares during the […] - 2025-02-03 08:57:17
iShares MSCI World EUR Hedged UCITS ETF (Acc) BMRN holdings
| Date | Number of BMRN Shares Held | Base Market Value of BMRN Shares | Local Market Value of BMRN Shares | Change in BMRN Shares Held | Change in BMRN Base Value | Current Price per BMRN Share Held | Previous Price per BMRN Share Held |
|---|
| 2025-05-08 (Thursday) | 11,393 | USD 604,327 | USD 604,327 | | | | |
| 2025-05-07 (Wednesday) | 11,393 | USD 594,531 | USD 594,531 | 0 | USD -4,524 | USD 52.1839 | USD 52.581 |
| 2025-05-06 (Tuesday) | 11,393 | USD 599,055 | USD 599,055 | 160 | USD -15,716 | USD 52.581 | USD 54.729 |
| 2025-05-05 (Monday) | 11,233 | USD 614,771 | USD 614,771 | 0 | USD 1,891 | USD 54.729 | USD 54.5607 |
| 2025-05-02 (Friday) | 11,233 | USD 612,880 | USD 612,880 | 40 | USD -9,301 | USD 54.5607 | USD 55.5866 |
| 2025-05-01 (Thursday) | 11,193 | USD 622,181 | USD 622,181 | 123 | USD 1,949 | USD 55.5866 | USD 56.0282 |
| 2025-04-30 (Wednesday) | 11,070 | USD 620,232 | USD 620,232 | 0 | USD 4,859 | USD 56.0282 | USD 55.5892 |
| 2025-04-29 (Tuesday) | 11,070 | USD 615,373 | USD 615,373 | 160 | USD 11,531 | USD 55.5892 | USD 55.3476 |
| 2025-04-28 (Monday) | 10,910 | USD 603,842 | USD 603,842 | 40 | USD -1,401 | USD 55.3476 | USD 55.6801 |
| 2025-04-25 (Friday) | 10,870 | USD 605,243 | USD 605,243 | 40 | USD 7,824 | USD 55.6801 | USD 55.1633 |
| 2025-04-24 (Thursday) | 10,830 | USD 597,419 | USD 597,419 | 0 | USD 6,397 | USD 55.1633 | USD 54.5727 |
| 2025-04-23 (Wednesday) | 10,830 | USD 591,022 | USD 591,022 | 80 | USD 15,029 | USD 54.5727 | USD 53.5807 |
| 2025-04-22 (Tuesday) | 10,750 | USD 575,993 | USD 575,993 | 0 | USD 27,671 | USD 53.5807 | USD 51.0067 |
| 2025-04-21 (Monday) | 10,750 | USD 548,322 | USD 548,322 | 0 | USD -12,074 | USD 51.0067 | USD 52.1299 |
| 2025-04-18 (Friday) | 10,750 | USD 560,396 | USD 560,396 | 0 | USD 0 | USD 52.1299 | USD 52.1299 |
| 2025-04-17 (Thursday) | 10,750 | USD 560,396 | USD 560,396 | 0 | USD 4,881 | USD 52.1299 | USD 51.6758 |
| 2025-04-16 (Wednesday) | 10,750 | USD 555,515 | USD 555,515 | 80 | USD -9,822 | USD 51.6758 | USD 52.9838 |
| 2025-04-15 (Tuesday) | 10,670 | USD 565,337 | USD 565,337 | 80 | USD 9,449 | USD 52.9838 | USD 52.4918 |
| 2025-04-14 (Monday) | 10,590 | USD 555,888 | USD 555,888 | 0 | USD 25,197 | USD 52.4918 | USD 50.1125 |
| 2025-04-11 (Friday) | 10,590 | USD 530,691 | USD 530,691 | 120 | USD 3,281 | USD 50.1125 | USD 50.3734 |
| 2025-04-10 (Thursday) | 10,470 | USD 527,410 | USD 527,410 | 0 | USD -36,283 | USD 50.3734 | USD 53.8389 |
| 2025-04-09 (Wednesday) | 10,470 | USD 563,693 | USD 563,693 | 160 | USD 35,578 | USD 53.8389 | USD 51.2236 |
| 2025-04-08 (Tuesday) | 10,310 | USD 528,115 | USD 528,115 | 40 | USD -28,143 | USD 51.2236 | USD 54.1634 |
| 2025-04-07 (Monday) | 10,270 | USD 556,258 | USD 556,258 | 0 | USD -6,940 | USD 54.1634 | USD 54.8391 |
| 2025-04-04 (Friday) | 10,270 | USD 563,198 | USD 563,198 | 0 | USD -83,094 | USD 54.8391 | USD 62.9301 |
| 2025-04-02 (Wednesday) | 10,270 | USD 646,292 | USD 646,292 | 0 | USD 860 | USD 62.9301 | USD 62.8463 |
| 2025-04-01 (Tuesday) | 10,270 | USD 645,432 | USD 645,432 | 0 | USD -26,653 | USD 62.8463 | USD 65.4416 |
| 2025-03-31 (Monday) | 10,270 | USD 672,085 | USD 672,085 | 0 | USD -5,813 | USD 65.4416 | USD 66.0076 |
| 2025-03-28 (Friday) | 10,270 | USD 677,898 | USD 677,898 | 0 | USD -14,790 | USD 66.0076 | USD 67.4477 |
| 2025-03-27 (Thursday) | 10,270 | USD 692,688 | USD 692,688 | 0 | USD 11,831 | USD 67.4477 | USD 66.2957 |
| 2025-03-26 (Wednesday) | 10,270 | USD 680,857 | USD 680,857 | 0 | USD 691 | USD 66.2957 | USD 66.2284 |
| 2025-03-25 (Tuesday) | 10,270 | USD 680,166 | USD 680,166 | 0 | USD -4,786 | USD 66.2284 | USD 66.6945 |
| 2025-03-24 (Monday) | 10,270 | USD 684,952 | USD 684,952 | 0 | USD 8,076 | USD 66.6945 | USD 65.9081 |
| 2025-03-21 (Friday) | 10,270 | USD 676,876 | USD 676,876 | 156 | USD 9,261 | USD 65.9081 | USD 66.009 |
| 2025-03-20 (Thursday) | 10,114 | USD 667,615 | USD 667,615 | 0 | USD 4,445 | USD 66.009 | USD 65.5695 |
| 2025-03-19 (Wednesday) | 10,114 | USD 663,170 | USD 663,170 | 39 | USD 3,736 | USD 65.5695 | USD 65.4525 |
| 2025-03-18 (Tuesday) | 10,075 | USD 659,434 | USD 659,434 | 0 | USD -609 | USD 65.4525 | USD 65.513 |
| 2025-03-17 (Monday) | 10,075 | USD 660,043 | USD 660,043 | 0 | USD 16,577 | USD 65.513 | USD 63.8676 |
| 2025-03-14 (Friday) | 10,075 | USD 643,466 | USD 643,466 | 0 | USD -11,622 | USD 63.8676 | USD 65.0211 |
| 2025-03-13 (Thursday) | 10,075 | USD 655,088 | USD 655,088 | 39 | USD 6,911 | USD 65.0211 | USD 64.5852 |
| 2025-03-12 (Wednesday) | 10,036 | USD 648,177 | USD 648,177 | 0 | USD 755 | USD 64.5852 | USD 64.51 |
| 2025-03-11 (Tuesday) | 10,036 | USD 647,422 | USD 647,422 | 0 | USD -19,607 | USD 64.51 | USD 66.4636 |
| 2025-03-10 (Monday) | 10,036 | USD 667,029 | USD 667,029 | 0 | USD 147 | USD 66.4636 | USD 66.449 |
| 2025-03-07 (Friday) | 10,036 | USD 666,882 | USD 666,882 | 0 | USD 3,130 | USD 66.449 | USD 66.1371 |
| 2025-03-05 (Wednesday) | 10,036 | USD 663,752 | USD 663,752 | 0 | USD -8,429 | USD 66.1371 | USD 66.977 |
| 2025-03-04 (Tuesday) | 10,036 | USD 672,181 | USD 672,181 | | | | |
| 2024-11-12 (Tuesday) | 9,744 | USD 607,353 | USD 607,353 | 39 | USD 2,431 | USD 62.331 | USD 62.331 |
| 2024-11-11 (Monday) | 9,705 | USD 604,922 | USD 604,922 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of BMRN by Blackrock for IE00B441G979
Show aggregate share trades of BMRN| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-05-06 | BUY | 160 | | | 52.581* | | 59.29 |
| 2025-05-02 | BUY | 40 | | | 54.561* | | 59.52 |
| 2025-05-01 | BUY | 123 | | | 55.587* | | 59.62 |
| 2025-04-29 | BUY | 160 | | | 55.589* | | 59.82 |
| 2025-04-28 | BUY | 40 | | | 55.348* | | 59.94 |
| 2025-04-25 | BUY | 40 | | | 55.680* | | 60.06 |
| 2025-04-23 | BUY | 80 | | | 54.573* | | 60.36 |
| 2025-04-16 | BUY | 80 | | | 51.676* | | 61.78 |
| 2025-04-15 | BUY | 80 | | | 52.984* | | 62.10 |
| 2025-04-11 | BUY | 120 | | | 50.113* | | 62.93 |
| 2025-04-09 | BUY | 160 | | | 53.839* | | 63.83 |
| 2025-04-08 | BUY | 40 | | | 51.224* | | 64.38 |
| 2025-03-21 | BUY | 156 | | | 65.908* | | 65.16 |
| 2025-03-19 | BUY | 39 | | | 65.570* | | 65.03 |
| 2025-03-13 | BUY | 39 | | | 65.021* | | 65.08 |
| 2024-11-12 | BUY | 39 | | | 62.331* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of BMRN
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-05-09 | 111,048 | 0 | 406,915 | 27.3% |
| 2025-05-08 | 229,822 | 59 | 583,186 | 39.4% |
| 2025-05-07 | 144,552 | 900 | 485,365 | 29.8% |
| 2025-05-06 | 205,031 | 1,340 | 499,836 | 41.0% |
| 2025-05-05 | 180,438 | 168 | 430,655 | 41.9% |
| 2025-05-02 | 430,077 | 3,788 | 904,432 | 47.6% |
| 2025-05-01 | 219,694 | 1,403 | 491,056 | 44.7% |
| 2025-04-30 | 235,058 | 26 | 390,531 | 60.2% |
| 2025-04-29 | 174,326 | 31 | 437,740 | 39.8% |
| 2025-04-28 | 127,460 | 254 | 523,544 | 24.3% |
| 2025-04-25 | 102,763 | 184 | 238,974 | 43.0% |
| 2025-04-24 | 121,268 | 1,606 | 361,577 | 33.5% |
| 2025-04-23 | 275,391 | 221 | 400,292 | 68.8% |
| 2025-04-22 | 269,870 | 1,503 | 576,869 | 46.8% |
| 2025-04-21 | 186,783 | 470 | 426,049 | 43.8% |
| 2025-04-17 | 160,393 | 87 | 316,388 | 50.7% |
| 2025-04-16 | 206,325 | 126 | 367,335 | 56.2% |
| 2025-04-15 | 230,108 | 940 | 627,328 | 36.7% |
| 2025-04-14 | 227,981 | 842 | 632,667 | 36.0% |
| 2025-04-11 | 177,321 | 327 | 857,724 | 20.7% |
| 2025-04-10 | 504,599 | 3,132 | 979,222 | 51.5% |
| 2025-04-09 | 376,563 | 2,136 | 1,505,394 | 25.0% |
| 2025-04-08 | 287,293 | 492 | 744,643 | 38.6% |
| 2025-04-07 | 397,089 | 3,588 | 1,598,590 | 24.8% |
| 2025-04-04 | 387,547 | 2,415 | 1,422,795 | 27.2% |
| 2025-04-03 | 193,095 | 0 | 648,102 | 29.8% |
| 2025-04-02 | 121,215 | 0 | 542,092 | 22.4% |
| 2025-04-01 | 115,325 | 0 | 427,655 | 27.0% |
| 2025-03-31 | 251,245 | 13,914 | 455,639 | 55.1% |
| 2025-03-28 | 190,559 | 0 | 493,391 | 38.6% |
| 2025-03-27 | 260,518 | 0 | 547,813 | 47.6% |
| 2025-03-26 | 244,045 | 2,886 | 546,385 | 44.7% |
| 2025-03-25 | 111,993 | 1,199 | 292,460 | 38.3% |
| 2025-03-24 | 104,078 | 42 | 304,119 | 34.2% |
| 2025-03-21 | 391,710 | 30 | 553,999 | 70.7% |
| 2025-03-20 | 183,806 | 11,851 | 323,579 | 56.8% |
| 2025-03-19 | 169,649 | 992 | 366,339 | 46.3% |
| 2025-03-18 | 146,912 | 131 | 376,154 | 39.1% |
| 2025-03-17 | 110,703 | 2,527 | 311,881 | 35.5% |
| 2025-03-14 | 262,788 | 2,376 | 450,080 | 58.4% |
| 2025-03-13 | 119,066 | 1 | 258,146 | 46.1% |
| 2025-03-12 | 139,647 | 12,744 | 389,910 | 35.8% |
| 2025-03-11 | 162,058 | 891 | 348,828 | 46.5% |
| 2025-03-10 | 212,225 | 1,129 | 531,131 | 40.0% |
| 2025-03-07 | 348,932 | 6,231 | 608,064 | 57.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.